Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
Clinical trial NCT02825251 · COMPLETED
Trial details
- NCT number
- NCT02825251
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-06
- Primary completion
- 2017-06-20
- Enrollment
- 472
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.